QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

GRDN

QT79Guardian Pharmacy Services, Inc.
NYSE·Healthcare·Medical - Distribution·USA
Latest market price
42.41
-0.99-2.28%
OverviewShort InterestFilings
GRDNQT79Guardian Pharmacy Services, Inc.·NYSE
OverviewShort InterestFilings
42.41-2.28%
TA
Loading chart...
Screen all →
MCK-3.74%$750.63COR-1.90%$271.83CAH-1.99%$221.77HSIC-0.06%$79.92PBH+1.80%$46.97
Snapshot
Index-P/E51.79EPS (ttm)0.83Insider Own-Shs Outstand63.32M
Perf Week-1.56%
Market Cap2.75BForward P/E31.22EPS next Y1.36Insider Trans55.46%Shs Float-Perf Month16.90%
Enterprise Value2.72BPEG0.25EPS next Q0.26Inst Own-Short Float-Perf Quarter23.32%
Income53.04MP/S1.89EPS this Y51.81%Inst Trans-Short Ratio-Perf Half Y38.41%
Sales1.46BP/B12.44EPS next Y7.80%ROA12.43%Short Interest-Perf YTD40.94%
Book/sh3.66P/C30.96EPS next 5Y9.35%ROE27.21%52W High44.00 -3.61%Perf Year115.61%
Cash/sh1.03P/FCF39.25EPS past 3/5Y-ROIC20.71%52W Low19.30 119.74%Perf 3Y-
Dividend Est.-EV/EBITDA26.59Sales past 3/5Y16.82% 14.51%Gross Margin20.93%Volatility2.09% 2.78%Perf 5Y-
Dividend TTM-EV/Sales1.87EPS Y/Y TTM164.41%Oper. Margin5.75%ATR (14)1.55Perf 10Y-
Dividend Ex-Date-Quick Ratio1.17Sales Y/Y TTM18.57%Profit Margin3.64%RSI (14)64.54Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.46EPS Q/Q38.10%SMA204.43%Beta0.77Target Price41.00
Payout0.00%Debt/Eq0.17Sales Q/Q2.43%SMA5010.20%Rel Volume2.57Prev Close43.40
Employees3,400LT Debt/Eq0.14EarningsAug 10SMA20031.09%Avg Volume390.87KPrice42.41
IPO DateApr 21, 2016Option/ShortYes / YesEPS/Sales Surpr.20.83% 2.12%Net Debt/EBITDA-0.27Volume1,002,692Change-2.28%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-17-26ReiteratedTruist Financial$43 → $47
Mar-12-26ReiteratedRaymond James$28 → $40
Mar-12-26ReiteratedTruist Financial$34 → $38
Jan-14-26ReiteratedStephens$35 → $36
Nov-14-25ReiteratedTruist Financial$30 → $34
Oct-10-25InitiatedOppenheimerOutperform$30
Sep-26-25ReiteratedTruist Financial$28 → $30
May-14-25ReiteratedRaymond James$25 → $28
Latest News
Jun-17-26
Jun-17-2610:48AM
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47Benzinga
07:59AM
B of A Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $47Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,4561,4491,228
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,1511,167984
Gross Profit305282244
Selling, General and Administrative Excl. Other222193307
Research and Development
000
Other Operating Expense000
Operating Income8589-63
Interest Expense013
Unusual Expense
———
Non-Operating Income (Expense)4150
Net Income Before Taxes7973-66
Income Taxes26245
Consolidated Net Income5349-87
Net Income From Continuing Operations5449-71
Net Income5349-87
EPS (Recurring)0.850.79-1.77
EPS (Basic, Before Extraordinaries)0.850.79-1.77
EPS (Diluted)0.830.78-1.77
EBITDA10296-43
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio51.1038.58—
Price To Sales Ratio1.841.29—
Gross Margin20.9519.4619.87
Operating Margin5.846.14-5.13
Net Margin3.643.38-7.08
Shares Outstanding636262
Market Capitalization2,6721,866—
Operating Lease Expense
———
Insider Trading Volume
$49.24$46.75$44.27$41.79$39.30● Close Price0.00M104.81M209.63M314.44M419.26MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Pharmacy Investors, LLCother: Member of 10% owner groupMar 28 '26Option Exercise0.002,827,87802,449,867Mar 31 12:00 AM
BINDLEY WILLIAM Edirector, 10 percent owner:Mar 28 '26Option Exercise0.0012,200,350010,569,491Mar 31 12:00 AM
Forbes KendallSee RemarksMar 28 '26Option Exercise0.001,217,14001,061,826Mar 31 12:00 AM
Morris David KSee RemarksMar 28 '26Option Exercise0.001,283,7380896,341Mar 31 12:00 AM
Cardinal Equity Fund, L.P.other: Member of 10% owner groupMar 28 '26Option Exercise0.00942,1140816,180Mar 31 12:00 AM
Bindley Capital Partners I, LLC10% OwnerMar 28 '26Option Exercise0.0012,200,350010,569,491Mar 31 12:00 AM
Salentine Thomas J Jrdirector, 10 percent owner:Mar 28 '26Option Exercise0.0012,200,350010,569,491Mar 31 12:00 AM
Ackerman JohnDirectorMar 28 '26Option Exercise0.003,769,99202,449,867Mar 31 12:00 AM
Burke FredSee RemarksMar 28 '26Option Exercise0.002,597,65202,139,239Mar 31 12:00 AM
Morris David KSee RemarksMar 20 '26Sale29.68187,8555,576,006254,472Mar 24 12:00 AM
Pharmacy Investors, LLCother: Member of 10% owner groupMar 20 '26Sale29.68827,63624,566,3061,035,928Mar 24 12:00 AM
Burke FredSee RemarksMar 20 '26Sale29.68671,43219,929,780840,413Mar 24 12:00 AM
Forbes KendallSee RemarksMar 20 '26Sale29.68346,67210,290,092453,256Mar 24 12:00 AM
Cardinal Equity Fund, L.P.other: Member of 10% owner groupMar 20 '26Sale29.68275,7288,184,296345,123Mar 24 12:00 AM
Salentine Thomas J Jrdirector, 10 percent owner:Mar 20 '26Sale29.683,570,677105,986,6204,469,316Mar 24 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR